Last update 22 Dec 2024

Emetine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Emetine hydrochloride (USP), ACER-2820, NSC-33669
Target
Mechanism
EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), Virus replication inhibitors
Inactive Indication-
Originator Organization-
Inactive Organization
Drug Highest PhasePhase 2/3
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC29H56Cl2N2O11
InChIKeySFEHUASGOSYSBB-HPXHXMBCSA-N
CAS Registry79300-08-6

External Link

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 3
US
15 May 2024
COVID-19Phase 3
US
15 May 2024
COVID-19Phase 3
US
15 May 2024
COVID-19Phase 3
NP
15 May 2024
COVID-19Phase 3
NP
15 May 2024
COVID-19Phase 3
NP
15 May 2024
Stickler Syndrome, Type 1Preclinical
GB
01 Jul 2018
Non-Small Cell Lung CancerPreclinical
TW
01 Jul 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
-
ujhvhoawtg(cnxngudwmr) = Emetine is an ingredient of the root of Carapichea Ipecacuanha, and its oral administration cause acute severe vomiting. qrfjtylrfa (lmhttjecxs )
-
13 Nov 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free